Back to search

Article

Viral RNA level, serum antibody responses, and transmission risk in discharged COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study

2020-07-26

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Managing discharged COVID-19 (DC) patients with recurrent positive (RP) SARS-CoV-2 RNA test results is challenging. We aimed to comprehensively characterize the viral RNA level and serum antibody responses in RP-DC patients and evaluate their viral transmission risk. <h4>Methods</h4> A population-based observational cohort study was performed on 479 DC patients discharged from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
66f6d767-ecb1-5189-80f6-352697b5eb15
DOI
10.1101/2020.07.21.20125138
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Viral RNA level, serum antibody responses, and transmission risk in discharged COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort studyDOI 10.1101/2020.07.21.20125138
Incidence rate, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: a prospective cohort studySemantic proximity
Re-positive discharged COVID-19 patients are at low transmission risk for SARS-CoV-2 infection– a finding from recovered COVID-19 patients in Wuhan, ChinaSemantic proximity
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCRSemantic proximity
Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity
Immunological and Inflammatory Indicators of COVID-19 Patients With Returned-positive Nucleic Acid Tests During Hospitalization: a Retrospective Cohort StudySemantic proximity
Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infectionSemantic proximity
Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onsetSemantic proximity
Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity
Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19Semantic proximity
Analytical Performance of the Point-of-care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in FranceSemantic proximity
The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Semantic proximity
Virological and serological characterization of critically ill patients with COVID-19 in the UK: a special focus on variant detectionSemantic proximity
Select a neighboring publication to make it the new centre.